OBR Green Articles (ASH Conference Coverage)

article

February 2017Edition

Barriers to clinical trial participation, such as the lack of ethnic and racial diversity and low numbers for the elderly, have plagued clinical trial enrollment. Crowd-funded patient-centric websites, advocacy organizations, and pharma companies ar...

article

February 2017Edition

Global multicenter studies of CAR T-cells like Novartis’ ELIANA in ALL and Kite Pharma’s ZUMA-1 in NHL have researchers excited due to both successful patient outcomes and also their now proven scalability. With registration trials like these, th...